RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,403 | -30.9% | 8,608,946 | +3.2% | 0.01% | -26.7% |
| Q2 2023 | $104,820 | -7.3% | 8,345,517 | +21.6% | 0.02% | -11.8% |
| Q1 2023 | $113,034 | +68.4% | 6,862,960 | +52.7% | 0.02% | +54.5% |
| Q4 2022 | $67,126 | -99.9% | 4,493,004 | -1.5% | 0.01% | -35.3% |
| Q3 2022 | $102,039,000 | +14.9% | 4,561,363 | -13.9% | 0.02% | +54.5% |
| Q2 2022 | $88,780,000 | -40.7% | 5,300,307 | +6.0% | 0.01% | -26.7% |
| Q1 2022 | $149,642,000 | +17.3% | 4,999,718 | +20.3% | 0.02% | +36.4% |
| Q4 2021 | $127,611,000 | +150.1% | 4,155,341 | +156.8% | 0.01% | +120.0% |
| Q3 2021 | $51,014,000 | +18.8% | 1,617,953 | +37.9% | 0.01% | +25.0% |
| Q2 2021 | $42,938,000 | -17.5% | 1,173,482 | -22.0% | 0.00% | -20.0% |
| Q1 2021 | $52,031,000 | +61.8% | 1,505,092 | +94.6% | 0.01% | +66.7% |
| Q4 2020 | $32,150,000 | -4.1% | 773,575 | -1.8% | 0.00% | -25.0% |
| Q3 2020 | $33,540,000 | – | 787,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |